“…Based on preliminary information from studies suggesting that liver stiffness measurement (LSM) by transient elastography, in combination with other noninvasive parameters, was useful for "ruling out" patients with cACLD needing screening endoscopy, (4)(5)(6)(7) the Baveno VI recommendations indicated that patients with cACLD, an LSM <20 kPa, and a platelet count >150 3 10 9 cells/L have a very low risk of VNT and consequently can safely avoid the screening endoscopy. (1) Following that recommendation, several studies have now confirmed the validity of this risk classification rule, (8)(9)(10)(11) which allows sparing between 10% to 30% of screening endoscopies with a very low risk of missing VNT. However, due to the low prevalence of VNT in these patients with cACLD (<10%), up to 40% of unneeded endoscopies would still be performed.…”